Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3
Top Cited Papers
- 1 January 2008
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 9 (1) , 29-38
- https://doi.org/10.1016/s1470-2045(07)70384-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Recursive Partitioning Analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized TrialJournal of Clinical Oncology, 2006
- Prospective Study of Quality of Life in Adults with Newly Diagnosed High-grade GliomasJournal of Neuro-Oncology, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysisNeuro-Oncology, 2004
- Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approachZeitschrift für Krebsforschung und Klinische Onkologie, 2003
- Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant TemozolomideJournal of Clinical Oncology, 2002
- Validation and Predictive Power of Radiation Therapy Oncology Group (RTOG) Recursive Partitioning Analysis Classes for Malignant Glioma Patients: A Report Using RTOG 90-06☆International Journal of Radiation Oncology*Biology*Physics, 1998
- A bootstrap resampling procedure for model building: Application to the cox regression modelStatistics in Medicine, 1992
- Glucocorticoid Dependency as A Prognostic Factor in Radiotherapy for Cerebral GliomasActa Oncologica, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958